Medicines New Zealand: Media Releases

Media Releases

Release of Valuing Life Medicines Access Summit White Paper: A Good First Step

Funding boost and constructive collaboration will accelerate medicines access

Budget 2024 Medicines Investment: Broken Hearts and a Third-World Position

Medicines New Zealand Publishes 2022 Transfer of Value Reports, Reinforcing Commitment to Transparency in the Biopharmaceutical Industry

Medicines New Zealand congratulates Dr Peter Jansen on his new HQSC role and welcomes new Independent Chair, Mr Todd Krieble

Medicines New Zealand is pleased to announce a new Independent Chair and a Te Ao Māori Director

Medicines New Zealand Award recipient to develop novel biological ingredients into a tool that enhances patient healing and recovery after surgery.

New Zealand, it's time to put Fairness in Focus

PHARMAC Review: A step in the right direction, but 'devil will be in the detail' for Government on actions to be taken

Budget 2022 Medicines Investment: A start, but also a potential rapid and painful stop?

Medicines Sector Actively Responds to the Ukraine Crisis in Europe

Trans-Tasman Medicines Report: New Zealand Appalling Inequity Gap Exposed

International Medicines Report: New Zealand Past the Point of No Return?

Boring Budget 2021 reinforces two tier medicines access system in New Zealand

Medicines New Zealand supportive of Government’s PHARMAC Review assuming it is not a box-ticking exercise

Medicines New Zealand and the New Zealand Medical Association launch Transparency Initiative

EU export restrictions on COVID-19 vaccines may jeopardise global supply

PHARMAC Inquiry: “nothing should be off the table”

Collaborative Consultation on Medicines Policy Closes

Solutions for the Future: A New Medicines Landscape

It’s time to put fairness into focus

Dire findings - NZ continues to rank last for modern medicines access

Medicines New Zealand consulting on a new generation medicines policy

Clinical trials of medicines worth more than $1.2 billion to New Zealand

New Zealand’s medicines system still on life-support but can be saved

Cracking COVID-19: Collaboration is Key says Medicines New Zealand

Increased likelihood of several suitable COVID-19 vaccines being developed

Biopharmaceutical sector waging war on COVID-19 with over 60 vaccines and medicines

Growing Medicines Waiting List an International Disgrace

Some Positives but also Unanswered Questions in Government's Cancer Announcement

Medicines Access Crisis - Government Budget Ignores Patient Wellbeing

New Zealand research set to impact international opioid crisis

Outdated public funding model failing NZ patients

Applications closing soon for Value of Medicines Award 2018

Rewarding research that continues the evolution of medicine

Visiting patient advocates say New Zealand isn’t treating its cancer patients fairly

New Zealand’s Medicines Waiting List: International disgrace for patient equity

Rationing medicines by stealth with Government budget announcement

230,000 New Zealand patients have inequitable access to modern medicines

New Zealand research influences international treatment guidelines for gout

New independent chair wants improved equitable access to breakthrough medicines

Medicines New Zealand seeks independent chair for 2018

Researchers succeed after winning the Value of Medicines Award

Recognising Research Excellence with the 2017 Value Of Medicines Award

Founder of HPV Vaccine guest of honour at Parliamentary Dinner

NZ rolls out red carpet for inventor of world’s first cancer vaccine

Medicines in New Zealand are overlooked and underfunded

Patient voice prompts new medicines funding

Paracetamol wins Wellington researchers $20,000 prize

Research shows new cancer medicines pay for themselves

Economist visits New Zealand to present ground-breaking cancer research